• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    AstraZeneca PLC - American Depositary Shares (NY:AZN)

    161.58 +1.57 (+0.98%)
    Streaming Delayed Price Updated: 10:11 AM EDT, Aug 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 356,063
    Open 162.14
    Bid (Size) 161.52 (300)
    Ask (Size) 161.59 (200)
    Prev. Close 160.01
    Today's Range 160.94 - 162.18
    52wk Range 153.41 - 212.71
    Shares Outstanding N/A
    Dividend Yield 0.58%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
    From Pomerantz LLP
    Via GlobeNewswire

    Performance

    YTD
    -14.2%
    -14.2%
    1 Month
    -16.3%
    -16.3%
    3 Month
    -11.5%
    -11.5%
    6 Month
    -13.7%
    -13.7%
    1 Year
    -14.2%
    -14.2%

    More News

    Read More
    News headline image
    Astrazeneca Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics ETFs Earnings
    News headline image
    Sonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers
    From AstraZeneca
    Via Business Wire
    News headline image
    AstraZeneca results: H1 and Q2 2026
    From AstraZeneca
    Via Business Wire
    News headline image
    AZN Investors Have Opportunity to Join AstraZeneca PLC Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AstraZeneca PLC- AZN
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions ↗
    Via MarketBeat
    News headline image
    AZN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AstraZeneca (AZN)
    From Levi & Korsinsky, LLP
    Via Business Wire
    News headline image
    AstraZeneca Updates 2030 Sustainability Goals as AI and Emissions Cuts Take Center Stage ↗
    Via MarketBeat
    Topics Artificial Intelligence Climate Change ETFs
    News headline image
    IEFA vs. VXUS: Both Are Cheap. Both Are Broad. Here Is the Key Difference Long-Term Investors Need to Understand. ↗
    Via The Motley Fool
    Topics ETFs
    News headline image
    AstraZeneca and YMCA of the USA Announce Landmark Partnership Aimed to Address Gaps in Cancer Care
    From AstraZeneca
    Via Business Wire
    BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Targets Next Wave of DNA Damage Response Cancer Therapies
    Via Investor Brand Network
    Topics Artificial Intelligence
    Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
    Via Investor Brand Network
    News headline image
    TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
    From AstraZeneca
    Via Business Wire
    News headline image
    IXUS vs. IEFA: Which International ETF Is Better for Most Investors? ↗
    Via The Motley Fool
    Topics ETFs
    News headline image
    Camizestrant Combination Delayed Time to First Progression by 55% and to Second Progression by 37% in Patients With Advanced HR-positive Breast Cancer With an Emergent ESR1 Tumor Mutation in SERENA-6 Trial
    From AstraZeneca
    Via Business Wire
    News headline image
    IMFINZI® (durvalumab) plus IMJUDO® (tremelimumab-actl) combined with lenvatinib and TACE reduced the risk of disease progression or death by 30% in embolization-eligible unresectable liver cancer in EMERALD-3 Phase III trial
    From AstraZeneca
    Via Business Wire
    News headline image
    IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
    From AstraZeneca
    Via Business Wire
    News headline image
    Marathon Halves Its Copa Stake—The Panama Hub Advantage Still Stands ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor candidates
    From AstraZeneca
    Via Business Wire
    News headline image
    AstraZeneca to showcase Phase III data in liver, breast and bladder cancers and potential first-in-class rare disease therapy at ASCO 2026
    From AstraZeneca
    Via Business Wire
    News headline image
    3 International ETFs for Investors Looking Beyond U.S. Stocks ↗
    Via The Motley Fool
    Topics Artificial Intelligence ETFs
    News headline image
    As U.S. Debt Surpasses GDP, These 2 ETFs Are Emerging Winners in the “Sell America” Trade ↗
    Via MarketBeat
    Topics Credit Cards ETFs Economy

    Frequently Asked Questions

    Is AstraZeneca PLC - American Depositary Shares publicly traded?
    Yes, AstraZeneca PLC - American Depositary Shares is publicly traded.
    What exchange does AstraZeneca PLC - American Depositary Shares trade on?
    AstraZeneca PLC - American Depositary Shares trades on the New York Stock Exchange
    What is the ticker symbol for AstraZeneca PLC - American Depositary Shares?
    The ticker symbol for AstraZeneca PLC - American Depositary Shares is AZN on the New York Stock Exchange
    What is the current price of AstraZeneca PLC - American Depositary Shares?
    The current price of AstraZeneca PLC - American Depositary Shares is 161.58
    When was AstraZeneca PLC - American Depositary Shares last traded?
    The last trade of AstraZeneca PLC - American Depositary Shares was at 08/07/26 10:11 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.